The suit, filed in Cleveland County District Court, names Purdue Pharma, Johnson & Johnson, Allergan and units of Teva Pharmaceutical Industries as defendants.
The lawsuit alleges the drugmakers conducted a “fraudulent, decades-long marketing campaign to profit from the suffering of thousands of Oklahomans,” said Mr. Hunter, according to Reuters. “The companies knowingly marketed their drugs as safe for chronic pain management while downplaying the risk of opioid dependency.”
With the suit, Oklahoma joins the ranks of states like Ohio and Missouri, where state AGs previously filed similar lawsuits.
In statements obtained by Reuters, Johnson & Johnson said its medications carry U.S. Food and Drug Administration-mandated warnings; Allergan said it supports the safe, responsible use of prescription medications; Teva said it is committed to the promotion of safe opioid use; and Purdue said it denies the lawsuit’s allegations, but shares Mr. Hunter’s concerns regarding the opioid epidemic.
More articles on opioids:
UMass Memorial failed to report 80 substance-exposed births to child services, audit finds
Senate adds $45B to BCRA for opioid treatment
Opioid use disorder diagnoses for BCBS members sees nearly 500% increase since 2010
